A commonly encountered circulating autoantibody is the anti-nuclear antibody (ANA), which is checked in all patients undergoing ILD evaluation at our institution, and has been described in up to 35% of patients with IPF [20] and 82% of patients with IPAF [5]. This evidence concerns the gene BTG3 and idiopathic pulmonary fibrosis.